Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells

  1. Paula Freire-Pritchett
  2. Stefan Schoenfelder
  3. Csilla Várnai
  4. Steven W Wingett
  5. Jonathan Cairns
  6. Amanda J Collier
  7. Raquel García-Vílchez
  8. Mayra Furlan-Magaril
  9. Cameron S Osborne
  10. Peter J Fraser
  11. Peter J Rugg-Gunn  Is a corresponding author
  12. Mikhail Spivakov  Is a corresponding author
  1. The Babraham Institute, United Kingdom
  2. Universidad Nacional Autónoma de México, Mexico
  3. King's College London School of Medicine, United Kingdom

Abstract

Long-range cis-regulatory elements such as enhancers coordinate cell-specific transcriptional programmes by engaging in DNA looping interactions with target promoters. Deciphering the interplay between the promoter connectivity and activity of cis-regulatory elements during lineage commitment is crucial for understanding developmental transcriptional control. Here, we use Promoter Capture Hi-C to generate a high-resolution atlas of chromosomal interactions involving ~22,000 gene promoters in human pluripotent and lineage-committed cells, identifying putative target genes for known and predicted enhancer elements. We reveal extensive dynamics of cis-regulatory contacts upon lineage commitment, including the acquisition and loss of promoter interactions. This spatial rewiring occurs preferentially with predicted changes in the activity of cis-regulatory elements, and is associated with changes in target gene expression. Our results provide a global and integrated view of promoter interactome dynamics during lineage commitment of human pluripotent cells.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Paula Freire-Pritchett

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Stefan Schoenfelder

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Csilla Várnai

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Steven W Wingett

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Jonathan Cairns

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda J Collier

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Raquel García-Vílchez

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Mayra Furlan-Magaril

    Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico
    Competing interests
    The authors declare that no competing interests exist.
  9. Cameron S Osborne

    Department of Genetics and Molecular Medicine, King's College London School of Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Peter J Fraser

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Peter J Rugg-Gunn

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    For correspondence
    peter.rugg-gunn@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  12. Mikhail Spivakov

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    For correspondence
    mikhail.spivakov@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0383-3943

Funding

Wellcome (WT093736)

  • Peter J Rugg-Gunn

Biotechnology and Biological Sciences Research Council (BB/J004480/1)

  • Paula Freire-Pritchett
  • Stefan Schoenfelder
  • Csilla Várnai
  • Steven W Wingett
  • Jonathan Cairns
  • Mayra Furlan-Magaril
  • Peter J Fraser
  • Mikhail Spivakov

Medical Research Council (MR/J003808/1)

  • Amanda J Collier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Job Dekker, University of Massachusetts Medical School, United States

Version history

  1. Received: September 28, 2016
  2. Accepted: March 22, 2017
  3. Accepted Manuscript published: March 23, 2017 (version 1)
  4. Version of Record published: April 27, 2017 (version 2)

Copyright

© 2017, Freire-Pritchett et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,191
    views
  • 1,450
    downloads
  • 128
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Paula Freire-Pritchett
  2. Stefan Schoenfelder
  3. Csilla Várnai
  4. Steven W Wingett
  5. Jonathan Cairns
  6. Amanda J Collier
  7. Raquel García-Vílchez
  8. Mayra Furlan-Magaril
  9. Cameron S Osborne
  10. Peter J Fraser
  11. Peter J Rugg-Gunn
  12. Mikhail Spivakov
(2017)
Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells
eLife 6:e21926.
https://doi.org/10.7554/eLife.21926

Share this article

https://doi.org/10.7554/eLife.21926

Further reading

    1. Stem Cells and Regenerative Medicine
    Sarah Duchamp de Chastaigne, Catherine M Sawai
    Insight

    A new mathematical model can estimate the number of precursor cells that contribute to regenerating blood cells in mice.

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.